Published in Am J Physiol Regul Integr Comp Physiol on December 15, 2005
Impact of Dietary Sodium Restriction on Heart Failure Outcomes. JACC Heart Fail (2016) 2.08
Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure. J Card Fail (2011) 1.17
Renal renin secretion as regulator of body fluid homeostasis. Pflugers Arch (2012) 0.87
Quality and adequacy of dietary intake in a southern urban heart failure population. J Cardiovasc Nurs (2013) 0.82
Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure. Eur J Heart Fail (2015) 0.80
Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. Adv Ther (2015) 0.79
What should we tell patients with heart failure about sodium restriction and how should we counsel them? Curr Heart Fail Rep (2013) 0.79
Dietary sodium restriction below 2 g per day predicted shorter event-free survival in patients with mild heart failure. Eur J Cardiovasc Nurs (2013) 0.78
Dietary sodium adherence is poor in chronic heart failure patients. J Card Fail (2015) 0.77
Isolating the benefits of fluid restriction in patients with heart failure: A pilot study. Eur J Cardiovasc Nurs (2014) 0.76
An alternative hypothesis to the widely held view that renal excretion of sodium accounts for resistance to salt-induced hypertension. Kidney Int (2016) 0.75
Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study. Circ Heart Fail (2015) 0.75
Sodium restriction in heart failure: benefit or harm? Curr Treat Options Cardiovasc Med (2014) 0.75
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med (2010) 4.01
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat (2009) 2.54
Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol (2008) 2.42
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol (2011) 2.29
Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar). Eur Heart J (2012) 2.21
Mutations in the HERG K+-ion channel: a novel link between long QT syndrome and sudden infant death syndrome. Am J Cardiol (2005) 2.20
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J (2006) 2.12
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens (2006) 2.03
Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. Eur J Heart Fail (2014) 1.99
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med (2009) 1.95
Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol (2004) 1.77
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation (2007) 1.70
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction. Eur J Heart Fail (2005) 1.64
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci (2013) 1.61
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail (2014) 1.60
QT dynamics in risk stratification after myocardial infarction. Heart Rhythm (2005) 1.59
Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf (2009) 1.58
Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. Eur Heart J (2011) 1.54
Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant (2010) 1.53
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol (2009) 1.51
Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J (2005) 1.50
Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients. J Hypertens (2015) 1.45
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens (2008) 1.45
The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote. Circ Cardiovasc Genet (2013) 1.44
The genetic basis of Brugada syndrome: a mutation update. Hum Mutat (2009) 1.44
High mortality among heart failure patients treated with antidepressants. Int J Cardiol (2010) 1.42
Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach. Cancer Treat Rev (2010) 1.42
The influence of high versus low sodium intake on blood pressure and haemodynamics in patients with morbid obesity. J Hypertens (2013) 1.40
Diagnosis of the syndrome of inappropriate secretion of antidiuretic hormone. South Med J (2009) 1.40
[The Mechanical Heart--HeartMate 1--Danish results]. Ugeskr Laeger (2007) 1.40
Paroxysmal atrial fibrillation is uncommon in outpatients with chronic heart failure. Scand Cardiovasc J (2008) 1.40
The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R). Heart Rhythm (2013) 1.40
Liberal versus restrictive fluid administration to improve recovery after laparoscopic cholecystectomy: a randomized, double-blind study. Ann Surg (2004) 1.39
Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs (2011) 1.39
Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a 5-year follow-up of 268 consecutive patients. Scand Cardiovasc J (2003) 1.39
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]. Ugeskr Laeger (2004) 1.38
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension (2005) 1.31
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J (2007) 1.30
Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol (2003) 1.24
Effects of truncated angiotensins in humans after double blockade of the renin system. Am J Physiol Regul Integr Comp Physiol (2003) 1.22
The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol (2009) 1.21
Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs. Am J Physiol Regul Integr Comp Physiol (2003) 1.12
Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sci (Lond) (2002) 1.09
[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage (2006) 1.06
Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br J Pharmacol (2012) 1.05
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail (2004) 1.05
Effects of ventilation on cardiac output determined by inert gas rebreathing. Clin Physiol Funct Imaging (2005) 1.05
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol (2010) 1.04
Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Heart Fail (2011) 1.02
Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant (2009) 1.01
Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure. Eur J Heart Fail (2011) 1.00
Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J (2007) 0.99
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J (2010) 0.98
"Central command" and insular activation during attempted foot lifting in paraplegic humans. Hum Brain Mapp (2005) 0.98
Automatic selection of the threshold value R for approximate entropy. IEEE Trans Biomed Eng (2008) 0.97
Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency? Mov Disord (2006) 0.96
Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Fail (2006) 0.94
Reference values of electrocardiogram repolarization variables in a healthy population. J Electrocardiol (2009) 0.94
Elevated renal perfusion pressure does not contribute to natriuresis induced by isotonic saline infusion in freely moving dogs. J Physiol (2004) 0.94
Vasorelaxation in space. Hypertension (2005) 0.94
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J (2002) 0.93
Fluid shifts, vasodilatation and ambulatory blood pressure reduction during long duration spaceflight. J Physiol (2015) 0.93
Reproducibility of heart rate variability, blood pressure variability and baroreceptor sensitivity during rest and head-up tilt. Blood Press Monit (2005) 0.92
Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction. Heart Rhythm (2012) 0.92
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest (2014) 0.92
Natriuresis induced by mild hypernatremia in humans. Am J Physiol Regul Integr Comp Physiol (2002) 0.92
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender. Biol Psychiatry (2006) 0.92
New descriptors of T-wave morphology are independent of heart rate. J Electrocardiol (2008) 0.91
Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail (2006) 0.91
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Cardiovasc Drugs Ther (2005) 0.90
Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study. Clin Drug Investig (2012) 0.90
Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure. Cardiovasc Drugs Ther (2008) 0.90
Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol (1985) (2005) 0.90
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study. BMJ (2003) 0.90
Effects of supine, prone, and lateral positions on cardiovascular and renal variables in humans. Am J Physiol Regul Integr Comp Physiol (2002) 0.90
Simultaneous determination of total body water and plasma volume in conscious dogs by the indicator dilution principle. J Nutr (2002) 0.89
Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial. Circulation (2013) 0.89
Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol (2003) 0.89
Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients. Clin Chem (2007) 0.88
Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients. Biochem Biophys Res Commun (2007) 0.88
Prognostic threshold levels of NT-proBNP testing in primary care. Eur Heart J (2008) 0.87
Three decades of heart transplantation in Scandinavia: long-term follow-up. Eur J Heart Fail (2012) 0.87
Renal renin secretion as regulator of body fluid homeostasis. Pflugers Arch (2012) 0.87
Mechanisms and management of exercise-induced asthma in elite athletes. J Asthma (2012) 0.87
Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report. BMC Neurol (2012) 0.87
Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure. Eur Heart J (2007) 0.87
Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care. Eur J Heart Fail (2013) 0.86
KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia. Diabetes (2013) 0.86
COX-2 disruption leads to increased central vasopressin stores and impaired urine concentrating ability in mice. Am J Physiol Renal Physiol (2011) 0.86
Is it possible to predict hypotension during onset of spinal anesthesia in elderly patients? J Clin Anesth (2009) 0.86
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study). Eur J Heart Fail (2013) 0.85
Beat-to-beat QT dynamics in healthy subjects. Ann Noninvasive Electrocardiol (2004) 0.85
Normotensive sodium loading in normal man: regulation of renin secretion during beta-receptor blockade. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison. Cardiology (2004) 0.85